Synthesis, metal chelate stability studies, enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates

Min Li, Claude F. Meares

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

By directly coupling a tetrapeptide to DOTA through an amide bond, we synthesized a novel DOTA derivative, DOTA-glycylglycylglycyl-L-p-nitrophenylalanine amide. We converted this new precursor bifunctional chelating agent to DOTA-glycylglycylglycyl-L-p-isothiocyanatophenylalanine and conjugated it to monoclonal antibody Lym-1. Serum stability studies show that the radiolabeled conjugates are kinetically inert under physiological conditions. The rates of loss of radiometals in human serum are 0.1 ± 0.1% per day for InIII, 0.02 ± 0.15% per day for YIII, and 0.3 ± 0.2% per day for CuII labeled immunoconjugates. In the presence of the liver enzyme cathepsin B, an in vitro digestion of 114mIn-labeled conjugate yields a small fragment containing 114mIn. Characterization of the cleavage products shows that this liver enzyme hydrolyzes the peptide linkage before the phenylalanine residue, freeing the In-DOTA-triglycine complex from the conjugate. However, the liver enzyme cathepsin D does not cleave the linkage over the span of 7 days.

Original languageEnglish (US)
Pages (from-to)275-283
Number of pages9
JournalBioconjugate Chemistry
Volume4
Issue number4
StatePublished - 1993

Fingerprint

Immunoconjugates
Enzyme Stability
Liver
Peptides
Digestion
Enzymes
Metals
Derivatives
Amides
glycyl-glycyl-glycine
Cathepsin B
Cathepsin D
Monoclonal antibodies
Chelating Agents
Chelation
Serum
Phenylalanine
Cathepsins

ASJC Scopus subject areas

  • Chemistry(all)
  • Organic Chemistry
  • Clinical Biochemistry
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry

Cite this

Synthesis, metal chelate stability studies, enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates. / Li, Min; Meares, Claude F.

In: Bioconjugate Chemistry, Vol. 4, No. 4, 1993, p. 275-283.

Research output: Contribution to journalArticle

@article{eaa4e161e1cd4279adb67131b17a484a,
title = "Synthesis, metal chelate stability studies, enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates",
abstract = "By directly coupling a tetrapeptide to DOTA through an amide bond, we synthesized a novel DOTA derivative, DOTA-glycylglycylglycyl-L-p-nitrophenylalanine amide. We converted this new precursor bifunctional chelating agent to DOTA-glycylglycylglycyl-L-p-isothiocyanatophenylalanine and conjugated it to monoclonal antibody Lym-1. Serum stability studies show that the radiolabeled conjugates are kinetically inert under physiological conditions. The rates of loss of radiometals in human serum are 0.1 ± 0.1{\%} per day for InIII, 0.02 ± 0.15{\%} per day for YIII, and 0.3 ± 0.2{\%} per day for CuII labeled immunoconjugates. In the presence of the liver enzyme cathepsin B, an in vitro digestion of 114mIn-labeled conjugate yields a small fragment containing 114mIn. Characterization of the cleavage products shows that this liver enzyme hydrolyzes the peptide linkage before the phenylalanine residue, freeing the In-DOTA-triglycine complex from the conjugate. However, the liver enzyme cathepsin D does not cleave the linkage over the span of 7 days.",
author = "Min Li and Meares, {Claude F.}",
year = "1993",
language = "English (US)",
volume = "4",
pages = "275--283",
journal = "Bioconjugate Chemistry",
issn = "1043-1802",
publisher = "American Chemical Society",
number = "4",

}

TY - JOUR

T1 - Synthesis, metal chelate stability studies, enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates

AU - Li, Min

AU - Meares, Claude F.

PY - 1993

Y1 - 1993

N2 - By directly coupling a tetrapeptide to DOTA through an amide bond, we synthesized a novel DOTA derivative, DOTA-glycylglycylglycyl-L-p-nitrophenylalanine amide. We converted this new precursor bifunctional chelating agent to DOTA-glycylglycylglycyl-L-p-isothiocyanatophenylalanine and conjugated it to monoclonal antibody Lym-1. Serum stability studies show that the radiolabeled conjugates are kinetically inert under physiological conditions. The rates of loss of radiometals in human serum are 0.1 ± 0.1% per day for InIII, 0.02 ± 0.15% per day for YIII, and 0.3 ± 0.2% per day for CuII labeled immunoconjugates. In the presence of the liver enzyme cathepsin B, an in vitro digestion of 114mIn-labeled conjugate yields a small fragment containing 114mIn. Characterization of the cleavage products shows that this liver enzyme hydrolyzes the peptide linkage before the phenylalanine residue, freeing the In-DOTA-triglycine complex from the conjugate. However, the liver enzyme cathepsin D does not cleave the linkage over the span of 7 days.

AB - By directly coupling a tetrapeptide to DOTA through an amide bond, we synthesized a novel DOTA derivative, DOTA-glycylglycylglycyl-L-p-nitrophenylalanine amide. We converted this new precursor bifunctional chelating agent to DOTA-glycylglycylglycyl-L-p-isothiocyanatophenylalanine and conjugated it to monoclonal antibody Lym-1. Serum stability studies show that the radiolabeled conjugates are kinetically inert under physiological conditions. The rates of loss of radiometals in human serum are 0.1 ± 0.1% per day for InIII, 0.02 ± 0.15% per day for YIII, and 0.3 ± 0.2% per day for CuII labeled immunoconjugates. In the presence of the liver enzyme cathepsin B, an in vitro digestion of 114mIn-labeled conjugate yields a small fragment containing 114mIn. Characterization of the cleavage products shows that this liver enzyme hydrolyzes the peptide linkage before the phenylalanine residue, freeing the In-DOTA-triglycine complex from the conjugate. However, the liver enzyme cathepsin D does not cleave the linkage over the span of 7 days.

UR - http://www.scopus.com/inward/record.url?scp=0027636304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027636304&partnerID=8YFLogxK

M3 - Article

C2 - 8218484

AN - SCOPUS:0027636304

VL - 4

SP - 275

EP - 283

JO - Bioconjugate Chemistry

JF - Bioconjugate Chemistry

SN - 1043-1802

IS - 4

ER -